Leishmaniasis

Leishmaniasis
LeishmaniasisCutaneous leishmaniasis in the hand of a Central American adult Cutaneous leishmaniasis in the hand of a Central American adult
Ipins??w?? ati aw?n okunfa ita
ICD/CIM-10	B 55. B 55.
ICD/CIM-9	085 085
DiseasesDB	3266
MedlinePlus	001386

Leishmaniasis tabi leishmaniasis je arun kan ti protosan o si ntan kaakiri ni ni kete ti awon kokoro kan ba bu ni j?. kokoro . ^[1] Kokoro na le farahan l?na m?ta pataki gegebi: kut?n?s, mukokut?n?s,tabi fisera l??maniasisi. ^[1] Kot?n?s na ma a nwa pelu ogbe awo-ara,nigbati mukokut?n?s ma a nwa pelu ?gb? awo-ara, enu, ati imu, ati wipe fisera ma a nb?r? pelu ?gb? aw?-ara, nigba to ba ya iba, awon s??li ?j? pupa di?, ?l? inu ati ?d? to tobi. ^[1]^[2]

Okunfa ati iwadi [ atun?e | atun?e ami??r?? ]

O le ni ogun orisiri L??mania ti o nse okunfa akoran arun yi lara eniyan. ^[1] Awon ohun to fa ewu ni: osi, airiounj?-j?, pipa igbo run, ati kikun-ilu. ^[1] Orisi m?t??ta lo se e y?wo labe ?r? mikroskopu. ^[1] Lafikun, arun fisera se e y?wo nipa ay?wo ?j?. ^[2]

Idaduro ati itoju [ atun?e | atun?e ami??r?? ]

L??maniasisi se e daduro nipa sisun lab? aw?n ti o ni oogun-?f?n . ^[1] Awon igbes? miran ni fifi awon kokoro pelu oogun-efon ati titoju awon eniyan ti o ni arun yi lasiko ki o ma ba a tan kal?. ^[1] Iru itoju to ye se e m? nipa sise awari ibiti won ti ko arun na, awon iru L??mania , ati iru akoran. ^[1] Die lara awon oogun lilo fun arun fisera ni: liposoma amfoterisin B , ^[3] apap? pentafalenti antimoniasi ati paromomisini , ^[3] and miltefosine . ^[4]

Aw?n it??kasi [ atun?e | atun?e ami??r?? ]

↑ ^1.0 ^1.1 ^1.2 ^1.3 ^1.4 ^1.5 ^1.6 ^1.7 ^1.8 "Iwe oro otito lori L??maniasisi. N°375" . World Health Organization . January 2014 . Retrieved 17 February 2014 .
↑ ^2.0 ^2.1 Barrett, MP; Croft, SL (2012). "Management of trypanosomiasis and leishmaniasis." . British medical bulletin 104 : 175?96. doi : 10.1093/bmb/lds031 . PMC 3530408 . PMID 23137768 . //www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3530408 .
↑ ^3.0 ^3.1 Sundar, S; Chakravarty, J (Jan 2013). "L??maniasisi: famakoterapi ti igbalode.". Iro Amoye lori famakoterapi 14 (1): 53?63. doi : 10.1517/14656566.2013.755515 . PMID 23256501 .
↑ Dorlo, TP; Balasegaram, M; Beijnen, JH; de Vries, PJ (Nov 2012). "Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis.". The Journal of antimicrobial chemotherapy 67 (11): 2576?97. doi : 10.1093/jac/dks275 . PMID 22833634 .

[WHO2014-1] 1.0 ^1.1 ^1.2 ^1.3 ^1.4 ^1.5 ^1.6 ^1.7 ^1.8 "Iwe oro otito lori L??maniasisi. N°375" . World Health Organization . January 2014 . Retrieved 17 February 2014 .

[Barrett2012-2] 2.0 ^2.1 Barrett, MP; Croft, SL (2012). "Management of trypanosomiasis and leishmaniasis." . British medical bulletin 104 : 175?96. doi : 10.1093/bmb/lds031 . PMC 3530408 . PMID 23137768 . //www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3530408 .

[Sun2013-3] 3.0 ^3.1 Sundar, S; Chakravarty, J (Jan 2013). "L??maniasisi: famakoterapi ti igbalode.". Iro Amoye lori famakoterapi 14 (1): 53?63. doi : 10.1517/14656566.2013.755515 . PMID 23256501 .

[Dor2012-4] Dorlo, TP; Balasegaram, M; Beijnen, JH; de Vries, PJ (Nov 2012). "Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis.". The Journal of antimicrobial chemotherapy 67 (11): 2576?97. doi : 10.1093/jac/dks275 . PMID 22833634 .

[1]

[2]

[3]

[4]